Jerusalem Pharmaceuticals Co. Ltd.

PLSE:JPH Stock Report

Market Cap: US$68.9m

Jerusalem Pharmaceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Mohammed Mahmoud Masrouji

Chief executive officer

US$20.4k

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership29.2%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates


CEO

Mohammed Mahmoud Masrouji (57 yo)

no data

Tenure

US$20,400

Compensation

Dr. Mohammed Mahmoud Yousef Masrouji is the Founder of the Center for Private Sector Development. Dr. Masrouji serves as the President of the Friends of Birzeit University Association. He is the Founder an...


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.